Correlation Between Singular Genomics and Credit Suisse
Can any of the company-specific risk be diversified away by investing in both Singular Genomics and Credit Suisse at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Singular Genomics and Credit Suisse into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Singular Genomics Systems and Credit Suisse Group, you can compare the effects of market volatilities on Singular Genomics and Credit Suisse and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Singular Genomics with a short position of Credit Suisse. Check out your portfolio center. Please also check ongoing floating volatility patterns of Singular Genomics and Credit Suisse.
Diversification Opportunities for Singular Genomics and Credit Suisse
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Singular and Credit is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Singular Genomics Systems and Credit Suisse Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Credit Suisse Group and Singular Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Singular Genomics Systems are associated (or correlated) with Credit Suisse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Credit Suisse Group has no effect on the direction of Singular Genomics i.e., Singular Genomics and Credit Suisse go up and down completely randomly.
Pair Corralation between Singular Genomics and Credit Suisse
Given the investment horizon of 90 days Singular Genomics Systems is expected to generate 1.34 times more return on investment than Credit Suisse. However, Singular Genomics is 1.34 times more volatile than Credit Suisse Group. It trades about 0.01 of its potential returns per unit of risk. Credit Suisse Group is currently generating about -0.12 per unit of risk. If you would invest 6,270 in Singular Genomics Systems on September 6, 2024 and sell it today you would lose (4,145) from holding Singular Genomics Systems or give up 66.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 24.85% |
Values | Daily Returns |
Singular Genomics Systems vs. Credit Suisse Group
Performance |
Timeline |
Singular Genomics Systems |
Credit Suisse Group |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Singular Genomics and Credit Suisse Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Singular Genomics and Credit Suisse
The main advantage of trading using opposite Singular Genomics and Credit Suisse positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Singular Genomics position performs unexpectedly, Credit Suisse can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Credit Suisse will offset losses from the drop in Credit Suisse's long position.Singular Genomics vs. West Pharmaceutical Services | Singular Genomics vs. ResMed Inc | Singular Genomics vs. ICU Medical | Singular Genomics vs. AptarGroup |
Credit Suisse vs. Banco Bilbao Vizcaya | Credit Suisse vs. Agricultural Bank | Credit Suisse vs. Mitsubishi UFJ Financial | Credit Suisse vs. Barclays PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |